# Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen

NDC: 0002-8233
Generic name: Insulin lispro
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SUSPENSION
Routes: SUBCUTANEOUS
Marketing started: 20200212

FDA application: BLA021017

## Active ingredients

- INSULIN LISPRO: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-8233"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-8233
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e49f701d-c19f-4cb2-b63f-01a917b33abc